John M. Gill

2017

In 2017, John M. Gill earned a total compensation of $492.2K as Former Chief Executive Officer of PharmAthene at PharmAthene, a 71% decrease compared to previous year.

Compensation breakdown

Bonus$303,150
Option Awards$32,000
Salary$106,812
Other$50,273
Total$492,235

Gill received $303.2K in bonus, accounting for 62% of the total pay in 2017.

Gill also received $32K in option awards, $106.8K in salary and $50.3K in other compensation.

Rankings

In 2017, John M. Gill's compensation ranked 11,945th out of 14,666 executives tracked by ExecPay. In other words, Gill earned more than 18.6% of executives.

ClassificationRankingPercentile
All
11,945
out of 14,666
19th
Division
Manufacturing
4,703
out of 5,768
19th
Major group
Chemicals And Allied Products
1,715
out of 2,074
17th
Industry group
Drugs
1,420
out of 1,730
18th
Industry
Pharmaceutical Preparations
1,105
out of 1,329
17th
Source: SEC filing on July 26, 2018.

Gill's colleagues

We found three more compensation records of executives who worked with John M. Gill at PharmAthene in 2017.

2017

William Enright

PharmAthene

Chief Executive Officer

2017

Sybil Tasker

PharmAthene

Chief Medical Officer

2017

Elizabeth Czerepak

PharmAthene

Chief Financial Officer

You may also like